Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered & Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.2 Research Approach
2.2.1 Secondary Data
2.2.1.1 Key Data from Secondary Sources
2.2.2 Primary Data
2.2.2.1 Primary Sources
2.2.2.2 Key Data from Primary Sources
2.2.2.3 Key Industry Insights
2.2.2.4 Breakdown of Primary Interviews
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.1.1 Approach 1: Company Revenue Estimation Approach
2.3.1.2 Approach 2: Presentations of Companies and Primary Interviews
2.3.1.3 Growth Forecasts
2.3.1.4 CAGR Projections
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Market Share
2.6 Assumptions & Limitations
2.6.1 Study Assumptions
2.6.2 Growth Rate Assumptions
2.6.3 Limitations
2.7 Risk Assessment
2.7.1 Risk Assessment: Human Organoids Market

4.1 Human Organoids Market Overview
4.2 Human Organoids Market, by Product, 2024 vs. 2029
4.3 Human Organoids Market, by Source, 2024 vs. 2029
4.4 Human Organoids Market, by Type, 2024 vs. 2029
4.5 Human Organoids Market, by Application, 2024 vs. 2029
4.6 Human Organoids Market, by End-user, 2024 vs. 2029
4.7 Human Organoids Market: Geographic Growth Opportunities

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Focus on Developing Alternatives to Animal Testing
5.2.1.2 Rising R&D Funding and Venture Capital Investments
5.2.1.3 Increasing Research on Organoids
5.2.1.4 Increasing Prevalence of Non-Alcoholic Fatty Liver Disease
5.2.1.5 Need for Early Detection of Drug Toxicity to Minimize Financial Losses Caused by Late-Stage Drug Failure
5.2.2 Restraints
5.2.2.1 Issues Related to Incorporating Organoids into Existing Workflows
5.2.3 Opportunities
5.2.3.1 Increasing Focus on Drug Discovery Activities
5.2.3.2 Rising Demand for Organ Transplantation
5.2.3.3 Growth Opportunities in Emerging Economies
5.2.4 Challenges
5.2.4.1 Dearth of Skilled Professionals
5.3 Pricing Analysis
5.3.1 Average Selling Price, by Product
5.3.2 Average Selling Price, by Region
5.4 Patent Analysis
5.4.1 List of Major Patents
5.5 Value Chain Analysis
5.6 Supply Chain Analysis
5.7 Trade Analysis
5.7.1 Import Data (HS Code 3002)
5.7.2 Export Data (HS Code 3002)
5.8 Ecosystem Analysis
5.8.1 Role in Ecosystem
5.9 Porter's Five Forces Analysis
5.9.1 Threat of New Entrants
5.9.2 Threat of Substitutes
5.9.3 Bargaining Power of Buyers
5.9.4 Bargaining Power of Suppliers
5.9.5 Intensity of Competitive Rivalry
5.10 Key Stakeholders and Buying Criteria
5.10.1 Key Stakeholders in Buying Process
5.10.2 Key Buying Criteria
5.11 Regulatory Landscape
5.11.1 Key Regulations
5.11.1.1 North America
5.11.1.1.1 US
5.11.1.1.2 Canada
5.11.1.2 Europe
5.11.1.3 Asia-Pacific
5.11.1.3.1 China
5.11.1.3.2 Japan
5.11.1.3.3 India
5.11.1.4 Latin America
5.11.1.4.1 Brazil
5.11.1.4.2 Mexico
5.11.1.5 Middle East & Africa
5.11.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.11.2.1 North America
5.11.2.2 Europe
5.11.2.3 Asia-Pacific
5.11.2.4 Latin America
5.11.2.5 Rest of the World
5.12 Technology Analysis
5.12.1 Key Technologies
5.12.1.1 Stem Cell Technology
5.12.2 Complementary Technologies
5.12.2.1 3D Bioprinting
5.12.3 Adjacent Technologies
5.12.3.1 Organ-On-A-Chip
5.13 Key Conferences and Events in 2024-2025
5.14 Trends/Disruptions Impacting Customer's Business
5.15 Investment and Funding Scenario
5.16 Case Study Analysis
5.16.1 Case Study 1: Evaluation of Patient-Derived Organoids for Drug Sensitivity Testing in Metastatic Colorectal Cancer with Limited Treatment Options
5.16.2 Case Study 2: Developing Stable Organoid Models from Gastric Cancer Tissues for Personalized Medicine and Drug Screening
5.16.3 Case Study 3: Optimal Cultivation Periods for Bladder Cancer Organoids Based on Transcriptomic Plasticity
5.17 Impact of AI on Human Organoids Market
5.17.1 Key Use Cases

6.1 Introduction
6.2 Liver Models
6.2.1 2D Liver Models
6.2.1.1 Fresh Hepatocytes
6.2.1.1.1 Increased Drug Metabolism Studies to Drive Market
6.2.1.2 Cryopreserved Hepatocytes
6.2.1.2.1 High Quality and Response to Support Market Growth
6.2.1.3 Other 2D Liver Models
6.2.2 3D Liver Models
6.2.2.1 Liver Organoids
6.2.2.1.1 Support for Determining Pharmacology and Hepatic Toxicity of Drugs to Treat Nafld
6.2.2.2 3D Bioprinted Liver Models
6.2.2.2.1 Increased Use in Drug Discovery to Propel Market Growth
6.2.2.3 Liver Spheroids
6.2.2.3.1 Need for Better Approaches in Drug Discovery to Promote Adoption of Spheroids
6.2.2.4 Liver-On-A-Chip
6.2.2.4.1 Stricter Regulations on Animal Testing to Promote Adoption of in Vitro Systems Like Liver-On-A-Chip
6.2.2.5 Other 3D Liver Models
6.3 Kidney Models
6.3.1 2D Kidney Models
6.3.1.1 Fresh Kidney Cells
6.3.1.1.1 Accurate Representation and Functionality to Support Usage
6.3.1.2 Cryopreserved Kidney Cells
6.3.1.2.1 Long-Term Storage Benefits to Drive Market
6.3.1.3 Other 2D Kidney Models
6.3.2 3D Kidney Models
6.3.2.1 Kidney Organoids
6.3.2.1.1 Increasing Incidence of Chronic Kidney Disease to Boost Market Growth
6.3.2.2 3D Bioprinted Kidney Models
6.3.2.2.1 High Cost of Bioprinting to Hinder Market Growth
6.3.2.3 Kidney Spheroids
6.3.2.3.1 Feasibility of Studying Challenging Kidney Diseases to Drive Adoption
6.3.2.4 Other 3D Kidney Models
6.4 Pancreatic Models
6.4.1 2D Pancreatic Models
6.4.1.1 Fresh Pancreatic Cells
6.4.1.1.1 High Responsiveness to Stimuli to Support Demand
6.4.1.2 Cryopreserved Pancreatic Cells
6.4.1.2.1 Potential Use of Cryopreserved Cells in Regenerative Therapies and Transplantation to Increase Demand
6.4.1.3 Other 2D Pancreatic Models
6.4.2 3D Pancreatic Models
6.4.2.1 Pancreatic Organoids
6.4.2.1.1 Increasing Prevalence of Diabetes and Pancreatic Cancer to Drive Uptake of Pancreatic Organoids
6.4.2.2 3D Bioprinted Pancreatic Models
6.4.2.2.1 Precise Fabrication and Close Resemblance to Native Architecture to Drive Adoption
6.4.2.3 Pancreatic Spheroids
6.4.2.3.1 Improved Methods for 3D Cell Culture to Promote Spheroid Formation and Support Market Growth
6.4.2.4 Other 3D Pancreatic Models
6.5 Colorectal Models
6.5.1 2D Colorectal Models
6.5.1.1 Fresh Colorectal Cells
6.5.1.1.1 Increasing Incidence of Colorectal Cancer Worldwide to Heighten Demand for Fresh Cells
6.5.1.2 Cryopreserved Colorectal Cells
6.5.1.2.1 Ability to Thaw and Culture Cells on Demand to Support Efficient Research Process, Reducing Need for Continuous Tissue Sourcing
6.5.1.3 Other 2D Colorectal Models
6.5.2 3D Colorectal Models
6.5.2.1 Colorectal Organoids
6.5.2.1.1 Drive to Enhance Therapeutic Interventions Will Support Growth
6.5.2.2 3D Bioprinted Colorectal Models
6.5.2.2.1 Increasing Bioburden of Colorectal Cancer to Drive Market Growth
6.5.2.3 Colorectal Spheroids
6.5.2.3.1 Advantages in Determining Disease Mechanisms and Drug Testing to Drive Adoption
6.5.2.4 Other 3D Colorectal Models
6.6 Heart Models
6.6.1 2D Heart Models
6.6.1.1 Fresh Heart Cells
6.6.1.1.1 Importance in Regenerative Medicine Applications to Support Adoption
6.6.1.2 Cryopreserved Heart Cells
6.6.1.2.1 On-Demand Access for Clinical or Research Use to Drive Uptake of Cryopreserved Cells
6.6.1.3 Other 2D Heart Models
6.6.2 3D Heart Models
6.6.2.1 Heart Organoids
6.6.2.1.1 Rising Demand in Cardiogenesis Research to Propel Market Growth
6.6.2.2 3D Bioprinted Heart Models
6.6.2.2.1 High Production Costs to Hinder Adoption
6.6.2.3 Heart Spheroids
6.6.2.3.1 Challenges in Controlling Spheroid Morphology to Restrain Growth
6.6.2.4 Other 3D Heart Models
6.7 Lung Models
6.7.1 2D Lung Models
6.7.1.1 Fresh Lung Cells
6.7.1.1.1 Use of Fresh Lung Cells Gaining Momentum due to Their Ability to Accurately Replicate Native Lung Environment
6.7.1.2 Cryopreserved Lung Cells
6.7.1.2.1 Advancements in Slicing and Cryopreservation to Enable Creation of Thousands of Hpcls from a Single Lung
6.7.1.3 Other 2D Lung Models
6.7.2 3D Lung Models
6.7.2.1 Lung Organoids
6.7.2.1.1 Increased Adoption in Biological Research Areas to Boost Market Growth
6.7.2.2 3D Bioprinted Lung Models
6.7.2.2.1 Advancements in Bioinks to Support Uptake of 3D Bioprinted Lung Models
6.7.2.3 Lung Spheroids
6.7.2.3.1 Advantages of Physiologically Relevant Environments for Evaluating Drug Efficacy and Toxicity to Support Usage
6.7.2.4 Other 3D Lung Models
6.8 Other Products
6.8.1 2D Models (Other Products)
6.8.1.1 Fresh Cells (Other Products)
6.8.1.1.1 New Techniques for Isolating and Preserving Fresh Cells to Help Enhance Quality of Research
6.8.1.2 Cryopreserved Cells (Other Products)
6.8.1.2.1 Long-Term Storage Benefits and Advancements in Research to Support Adoption
6.8.1.3 Other 2D Models
6.8.2 3D Models (Other Products)
6.8.2.1 Organoids (Other Products)
6.8.2.1.1 Growing Focus on Collaboration Fosters Innovation in Organoid Development
6.8.2.2 3D Bioprinted Models (Other Products)
6.8.2.2.1 Lack of Suitable Bioinks for 3D Bioprinting Applications to Hamper Market Growth
6.8.2.3 Spheroids (Other Products)
6.8.2.3.1 Predictive Environment for Assessing Efficacy and Safety to Support Adoption
6.8.2.4 Other 3D Models (Other Products)

7.1 Introduction
7.2 Adult Stem Cells
7.2.1 Adult Stem Cells to Hold Largest Share of Market, by Source
7.3 Induced Pluripotent Stem Cells
7.3.1 Growing Demand for Personalized Medicine to Drive Uptake of Ipscs
7.4 Embryonic Stem Cells
7.4.1 Ethical Concerns Associated with Escs to Hinder Market Growth
7.5 Other Sources

8.1 Introduction
8.2 Ready-To-Use Products
8.2.1 Mass Production of Ready-To-Use Products to Drive Adoption
8.3 Customizable Products
8.3.1 Advancements in 3D Bioprinting to Propel Market Growth

9.1 Introduction
9.2 Matrigel Matrix Culture
9.2.1 Long-Standing Use and Effectiveness in Growing Organoids to Ensure Adoption
9.3 Air-Liquid Interface Culture
9.3.1 Increasing Prevalence of Diseases Affecting Epithelial Tissues to Drive Adoption
9.4 Suspension Culture
9.4.1 Cost-Effectiveness of Suspension Culture to Drive Market
9.5 3D Bioprinting Culture
9.5.1 Rising Demand for Personalized Medicine to Boost Market Growth
9.6 Other Culture Methods

10.1 Introduction
10.2 Oncology
10.2.1 Growing Focus on Personalized Medicine in Oncology to Drive Demand for Cancer Organoids
10.3 Liver Diseases
10.3.1 Increasing Incidence of Liver-Related Conditions to Drive Demand for Effective Research Models
10.4 Gastrointestinal Diseases
10.4.1 Wide Usage in Modeling Inflammatory Bowel Disease and Malignancies to Propel Market
10.5 Cardiovascular Diseases
10.5.1 Rising Incidence of Cardiovascular Diseases to Drive Market
10.6 Infectious Diseases
10.6.1 Use of Organoids in Developing Antiviral Drugs to Support Market Growth
10.7 Neurological Disorders
10.7.1 Growing Incidence of Neuropsychiatric Disorders to Fuel Uptake of Human Organoids
10.8 Other Disease Areas

11.1 Introduction
11.2 Developmental Biology
11.2.1 Technological Advancements in Stem Cell Research to Boost Market Growth
11.3 Drug Toxicity & Efficacy Testing
11.3.1 Increased Drug Development Costs to Drive Growth
11.4 Disease Pathology
11.4.1 Increased Demand for Advanced in Vitro Disease Studies to Augment Market Growth
11.5 Personalized Medicine
11.5.1 High Cost and Insufficient Data to Hamper Market Growth
11.6 Regenerative Medicine
11.6.1 Increasing Funding Activities to Propel Market Growth
11.7 Other Applications

12.1 Introduction
12.2 Pharmaceutical & Biotechnology Companies
12.2.1 Increasing Prevalence of Chronic Diseases to Propel Market Growth
12.3 Contract Research Organizations
12.3.1 Increasing Outsourcing of Clinical Research Services to Support Market Growth
12.4 Academic & Research Institutes
12.4.1 Rising Government Funding and Increasing Industry-Academia Collaborations to Drive Market
12.5 Other End-users

13.1 Introduction
13.2 North America
13.2.1 Macroeconomic Outlook for North America
13.2.2 US
13.2.2.1 Rising Prevalence of Chronic Respiratory Diseases and Organ Transplants to Expedite Growth
13.2.3 Canada
13.2.3.1 Growing Incidence of Cancer and Investments in Disease Diagnostics & Life Science Research to Drive Market
13.3 Europe
13.3.1 Macroeconomic Outlook for Europe
13.3.2 Germany
13.3.2.1 Higher Healthcare Spending and Organ Transplants to Favor Market Growth
13.3.3 UK
13.3.3.1 Rising Disease Prevalence to Drive Market Growth
13.3.4 France
13.3.4.1 Increasing Availability of Advanced Medical Technologies to Support Market Growth
13.3.5 Italy
13.3.5.1 Modernization of Healthcare Infrastructure to Support Market
13.3.6 Spain
13.3.6.1 Rising Incidences of Cancer to Drive Demand
13.3.7 Rest of Europe
13.4 Asia-Pacific
13.4.1 Macroeconomic Outlook for Asia-Pacific
13.4.2 China
13.4.2.1 Healthcare Infrastructure Improvements to Support Market Growth in China
13.4.3 Japan
13.4.3.1 Rising Biomedical & Medical Research to Support Market Growth
13.4.4 India
13.4.4.1 Large Patient Population and Developing Healthcare Sector to Drive Market
13.4.5 Australia
13.4.5.1 Rising Private and Public Funding for Research Activities to Drive Market
13.4.6 South Korea
13.4.6.1 Favorable Government Policies to Fuel Market Growth
13.4.7 Rest of Asia-Pacific
13.5 Latin America
13.5.1 Macroeconomic Outlook for Latin America
13.5.2 Brazil
13.5.2.1 Growing Pharmaceuticals Market and Budget Allocations to Boost Market
13.5.3 Mexico
13.5.3.1 Booming Medical Tourism to Support Growth
13.5.4 Rest of Latin America
13.6 Middle East & Africa
13.6.1 Growing Focus on Improving Quality of Life to Drive Market
13.6.2 Macroeconomic Outlook for Middle East & Africa
13.7 GCC Countries
13.7.1 Rising Focus on Advanced Health Infrastructure to Augment Market
13.7.2 Macroeconomic Outlook for GCC Countries

14.1 Introduction
14.2 Key Player Strategies/Right to Win
14.2.1 Overview of Strategies Adopted by Players in Human Organoids Market
14.3 Revenue Analysis, 2021-2023
14.4 Market Share Analysis, 2023
14.5 Company Evaluation Matrix: Key Players, 2023
14.5.1 Stars
14.5.2 Emerging Leaders
14.5.3 Pervasive Players
14.5.4 Participants
14.5.5 Company Footprint, Key Players, 2023
14.5.5.1 Company Footprint
14.5.5.2 Region Footprint
14.5.5.3 Product Footprint
14.5.5.4 Source Footprint
14.5.5.5 Application Footprint
14.6 Company Evaluation Matrix: Startups/SMEs, 2023
14.6.1 Progressive Companies
14.6.2 Responsive Companies
14.6.3 Dynamic Companies
14.6.4 Starting Blocks
14.6.5 Competitive Benchmarking of Startup/SME Players, 2023
14.7 Company Valuation and Financial Metrics
14.8 Brand/Product Comparative Analysis
14.8.1 Bioivt
14.8.2 Becytes Biotechnologies
14.9 Competitive Scenario
14.9.1 Product Launches
14.9.2 Deals

15.1 Key Players
15.1.1 Thermo Fisher Scientific Inc.
15.1.1.1 Business Overview
15.1.1.2 Products Offered
15.1.1.3 Recent Developments
15.1.1.3.1 Product Launches
15.1.1.3.2 Deals
15.1.1.4 Analyst's View
15.1.1.4.1 Right to Win
15.1.1.4.2 Strategic Choices
15.1.1.4.3 Weaknesses and Competitive Threats
15.1.2 Corning Incorporated
15.1.2.1 Business Overview
15.1.2.2 Products Offered
15.1.2.3 Recent Developments
15.1.2.3.1 Deals
15.1.2.4 Analyst's View
15.1.2.4.1 Right to Win
15.1.2.4.2 Strategic Choices
15.1.2.4.3 Weaknesses and Competitive Threats
15.1.3 Merck KGaA
15.1.3.1 Business Overview
15.1.3.2 Products Offered
15.1.3.3 Recent Developments
15.1.3.3.1 Deals
15.1.3.3.2 Expansions
15.1.3.4 Analyst's View
15.1.3.4.1 Right to Win
15.1.3.4.2 Strategic Choices
15.1.3.4.3 Weaknesses and Competitive Threats
15.1.4 Bioivt
15.1.4.1 Business Overview
15.1.4.2 Products Offered
15.1.4.3 Recent Developments
15.1.4.3.1 Deals
15.1.4.4 Analyst's View
15.1.4.4.1 Right to Win
15.1.4.4.2 Strategic Choices
15.1.4.4.3 Weaknesses and Competitive Threats
15.1.5 Hub Organoids Bv
15.1.5.1 Business Overview
15.1.5.2 Products Offered
15.1.5.3 Recent Developments
15.1.5.3.1 Deals
15.1.5.4 Analyst's View
15.1.5.4.1 Right to Win
15.1.5.4.2 Strategic Choices
15.1.5.4.3 Weaknesses and Competitive Threats
15.1.6 Bico
15.1.6.1 Business Overview
15.1.6.2 Products Offered
15.1.6.3 Recent Developments
15.1.6.3.1 Product Launches
15.1.6.3.2 Deals
15.1.6.3.3 Other Developments
15.1.7 Becytes Biotechnologies
15.1.7.1 Business Overview
15.1.7.2 Products Offered
15.1.8 Insphero
15.1.8.1 Business Overview
15.1.8.2 Products Offered
15.1.8.3 Recent Developments
15.1.8.3.1 Deals
15.1.9 Gba Group
15.1.9.1 Business Overview
15.1.9.2 Products Offered
15.1.9.3 Recent Developments
15.1.9.3.1 Deals
15.1.10 Kirkstall Ltd.
15.1.10.1 Business Overview
15.1.10.2 Products Offered
15.1.11 Mimetas Bv
15.1.11.1 Business Overview
15.1.11.2 Products Offered
15.1.11.3 Recent Developments
15.1.11.3.1 Product Launches
15.1.11.3.2 Deals
15.1.12 Neuromics
15.1.12.1 Business Overview
15.1.12.2 Products Offered
15.1.13 Primacyt Cell Culture Technology GmbH
15.1.13.1 Business Overview
15.1.13.2 Products Offered
15.1.14 Stemcell Technologies
15.1.14.1 Business Overview
15.1.14.2 Products Offered
15.1.14.3 Recent Developments
15.1.14.3.1 Expansions
15.2 Other Players
15.2.1 Acrobiosystems
15.2.2 Biopredic International
15.2.3 Cn Bio Innovations Ltd.
15.2.4 Cyprio
15.2.5 Emulate, Inc.
15.2.6 Kerafast, Inc.
15.2.7 Pandorum Technologies Pvt. Ltd.
15.2.8 Cyfuse Biomedical Kk
15.2.9 Neyroblastgx LLC
15.2.10 3Dnamics Inc.
15.2.11 Definigen Limited

16.1 Discussion Guide
16.2 Knowledgestore: The Subscription Portal
16.3 Customization Options

Table 1 Investments and Funds for Human Organoid Research
Table 2 Research Projects and Activities
Table 3 Average Selling Price of Human Organoid Products, by Type, 2022-2024
Table 4 Average Selling Price of Human Organoid Products, by Region, 2022-2024
Table 5 Human Organoids Market: List of Major Patents, 2022-2023
Table 6 Import Data for HS Code 3002, Which Includes Cell Cultures, Whether or Not Modified, 2019-2023 (USD Million)
Table 7 Export Data for HS Code 3002, Which Includes Cell Cultures, Whether or Not Modified, by Country, 2019-2023 (USD Million)
Table 8 Human Organoids Market: Role in Ecosystem
Table 9 Human Organoids Market: Porter's Five Forces
Table 10 Influence of Stakeholders on Buying Process of Human Organoids (%)
Table 11 Key Buying Criteria for Human Organoids, by Type
Table 12 North America: Key Regulatory Bodies, Government Agencies, and Other Organizations
Table 13 Europe: Key Regulatory Bodies, Government Agencies, and Other Organizations
Table 14 Asia-Pacific: Key Regulatory Bodies, Government Agencies, and Other Organizations
Table 15 Latin America: Key Regulatory Bodies, Government Agencies, and Other Organizations
Table 16 Rest of the World: Key Regulatory Bodies, Government Agencies, and Other Organizations
Table 17 Human Organoids Market: Detailed List of Key Conferences and Events, January 2024-December 2025
Table 18 Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 19 Liver Models: Key Products Offered, by Company
Table 20 Liver and Intrahepatic Bile Duct Cancer Incidence, 2022
Table 21 Human Organoids Market for Liver Models, by Region, 2022-2029 (USD Million)
Table 22 North America: Human Organoids Market for Liver Models, by Country, 2022-2029 (USD Million)
Table 23 Europe: Human Organoids Market for Liver Models, by Country, 2022-2029 (USD Million)
Table 24 Asia-Pacific: Human Organoids Market for Liver Models, by Country, 2022-2029 (USD Million)
Table 25 Latin America: Human Organoids Market for Liver Models, by Country, 2022-2029 (USD Million)
Table 26 Human Organoids Market for Liver Models, by Type, 2022-2029 (USD Million)
Table 27 2D Liver Models Market, by Region, 2022-2029 (USD Million)
Table 28 2D Liver Models Market, by Type, 2022-2029 (USD Million)
Table 29 Fresh Hepatocytes: Key Products Offered, by Company
Table 30 Fresh Hepatocytes Market, by Region, 2022-2029 (USD Million)
Table 31 Cryopreserved Hepatocytes: Key Products Offered, by Company
Table 32 Cryopreserved Hepatocytes Market, by Region, 2022-2029 (USD Million)
Table 33 Other 2D Liver Models Market, by Region, 2022-2029 (USD Million)
Table 34 3D Liver Models Market, by Region, 2022-2029 (USD Million)
Table 35 3D Liver Models Market, by Type, 2022-2029 (USD Million)
Table 36 Liver Organoids Market, by Region, 2022-2029 (USD Million)
Table 37 3D Bioprinted Liver Models Market, by Region, 2022-2029 (USD Million)
Table 38 Liver Spheroids Market, by Region, 2022-2029 (USD Million)
Table 39 Liver-On-A Chip Market, by Region, 2022-2029 (USD Million)
Table 40 Other 3D Liver Models Market, by Region, 2022-2029 (USD Million)
Table 41 Kidney Models: Key Products Offered, by Company
Table 42 Kidney Cancer Incidence, 2022
Table 43 Human Organoids Market for Kidney Models, by Region, 2022-2029 (USD Million)
Table 44 North America: Human Organoids Market for Kidney Models, by Country, 2022-2029 (USD Million)
Table 45 Europe: Human Organoids Market for Kidney Models, by Country, 2022-2029 (USD Million)
Table 46 Asia-Pacific: Human Organoids Market for Kidney Models, by Country, 2022-2029 (USD Million)
Table 47 Latin America: Human Organoids Market for Kidney Models, by Country, 2022-2029 (USD Million)
Table 48 Human Organoids Market for Kidney Models, by Type, 2022-2029 (USD Million)
Table 49 2D Kidney Models Market, by Region, 2022-2029 (USD Million)
Table 50 2D Kidney Models Market, by Type, 2022-2029 (USD Million)
Table 51 Fresh Kidney Cells Market, by Region, 2022-2029 (USD Million)
Table 52 Cryopreserved Kidney Cells Market, by Region, 2022-2029 (USD Million)
Table 53 Other 2D Kidney Models Market, by Region, 2022-2029 (USD Million)
Table 54 3D Kidney Models Market, by Region, 2022-2029 (USD Million)
Table 55 3D Kidney Models Market, by Type, 2022-2029 (USD Million)
Table 56 Kidney Organoids Market, by Region, 2022-2029 (USD Million)
Table 57 3D Bioprinted Kidney Models Market, by Region, 2022-2029 (USD Million)
Table 58 Kidney Spheroids Market, by Region, 2022-2029 (USD Million)
Table 59 Other 3D Kidney Models Market, by Region, 2022-2029 (USD Million)
Table 60 Pancreatic Models: Key Products Offered, by Company
Table 61 Pancreatic Cancer Incidence, 2022
Table 62 Human Organoids Market for Pancreatic Models, by Region, 2022-2029 (USD Million)
Table 63 North America: Human Organoids Market for Pancreatic Models, by Country, 2022-2029 (USD Million)
Table 64 Europe: Human Organoids Market for Pancreatic Models, by Country, 2022-2029 (USD Million)
Table 65 Asia-Pacific: Human Organoids Market for Pancreatic Models, by Country, 2022-2029 (USD Million)
Table 66 Latin America: Human Organoids Market for Pancreatic Models, by Country, 2022-2029 (USD Million)
Table 67 Human Organoids Market for Pancreatic Models, by Type, 2022-2029 (USD Million)
Table 68 2D Pancreatic Models Market, by Region, 2022-2029 (USD Million)
Table 69 2D Pancreatic Models Market, by Type, 2022-2029 (USD Million)
Table 70 Fresh Pancreatic Cells Market, by Region, 2022-2029 (USD Million)
Table 71 Cryopreserved Pancreatic Cells Market, by Region, 2022-2029 (USD Million)
Table 72 Other 2D Pancreatic Models Market, by Region, 2022-2029 (USD Million)
Table 73 3D Pancreatic Models Market, by Region, 2022-2029 (USD Million)
Table 74 3D Pancreatic Models Market, by Type, 2022-2029 (USD Million)
Table 75 Pancreatic Organoids Market, by Region, 2022-2029 (USD Million)
Table 76 3D Bioprinted Pancreatic Models Market, by Region, 2022-2029 (USD Million)
Table 77 Pancreatic Spheroids Market, by Region, 2022-2029 (USD Million)
Table 78 Other 3D Pancreatic Models Market, by Region, 2022-2029 (USD Million)
Table 79 Colorectal Models: Key Products Offered, by Company
Table 80 Colorectal Cancer Incidence, 2022
Table 81 Human Organoids Market for Colorectal Models, by Region, 2022-2029 (USD Million)
Table 82 North America: Human Organoids Market for Colorectal Models, by Country, 2022-2029 (USD Million)
Table 83 Europe: Human Organoids Market for Colorectal Models, by Country, 2022-2029 (USD Million)
Table 84 Asia-Pacific: Human Organoids Market for Colorectal Models, by Country, 2022-2029 (USD Million)
Table 85 Latin America: Human Organoids Market for Colorectal Models, by Country, 2022-2029 (USD Million)
Table 86 Human Organoids Market for Colorectal Models, by Type, 2022-2029 (USD Million)
Table 87 2D Colorectal Models Market, by Region, 2022-2029 (USD Million)
Table 88 2D Colorectal Models Market, by Type, 2022-2029 (USD Million)
Table 89 Fresh Colorectal Cells Market, by Region, 2022-2029 (USD Million)
Table 90 Cryopreserved Colorectal Cells Market, by Region, 2022-2029 (USD Million)
Table 91 Other 2D Colorectal Models Market, by Region, 2022-2029 (USD Million)
Table 92 3D Colorectal Models Market, by Region, 2022-2029 (USD Million)
Table 93 3D Colorectal Models Market, by Type, 2022-2029 (USD Million)
Table 94 Colorectal Organoids Market, by Region, 2022-2029 (USD Million)
Table 95 3D Bioprinted Colorectal Models Market, by Region, 2022-2029 (USD Million)
Table 96 Colorectal Spheroids Market, by Region, 2022-2029 (USD Million)
Table 97 Other 3D Colorectal Models Market, by Region, 2022-2029 (USD Million)
Table 98 Human Organoids Market for Heart Models, by Region, 2022-2029 (USD Million)
Table 99 North America: Human Organoids Market for Heart Models, by Country, 2022-2029 (USD Million)
Table 100 Europe: Human Organoids Market for Heart Models, by Country, 2022-2029 (USD Million)
Table 101 Asia-Pacific: Human Organoids Market for Heart Models, by Country, 2022-2029 (USD Million)
Table 102 Latin America: Human Organoids Market for Heart Models, by Country, 2022-2029 (USD Million)
Table 103 Human Organoids Market for Heart Models, by Type, 2022-2029 (USD Million)
Table 104 2D Heart Models Market, by Region, 2022-2029 (USD Million)
Table 105 2D Heart Models Market, by Type, 2022-2029 (USD Million)
Table 106 Fresh Heart Cells Market, by Region, 2022-2029 (USD Million)
Table 107 Cryopreserved Heart Cells Market, by Region, 2022-2029 (USD Million)
Table 108 Other 2D Heart Models Market, by Region, 2022-2029 (USD Million)
Table 109 3D Heart Models Market, by Region, 2022-2029 (USD Million)
Table 110 3D Heart Models Market, by Type, 2022-2029 (USD Million)
Table 111 Heart Organoids Market, by Region, 2022-2029 (USD Million)
Table 112 3D Bioprinted Heart Models Market, by Region, 2022-2029 (USD Million)
Table 113 Heart Spheroids Market, by Region, 2022-2029 (USD Million)
Table 114 Other 3D Heart Models Market, by Region, 2022-2029 (USD Million)
Table 115 Lung Models: Key Products Offered, by Company
Table 116 Lung Cancer Incidence,2022
Table 117 Human Organoids Market for Lung Models, by Region, 2022-2029 (USD Million)
Table 118 North America: Human Organoids Market for Lung Models, by Country, 2022-2029 (USD Million)
Table 119 Europe: Human Organoids Market for Lung Models, by Country, 2022-2029 (USD Million)
Table 120 Asia-Pacific: Human Organoids Market for Lung Models, by Country, 2022-2029 (USD Million)
Table 121 Latin America: Human Organoids Market for Lung Models, by Country, 2022-2029 (USD Million)
Table 122 Human Organoids Market for Lung Models, by Type, 2022-2029 (USD Million)
Table 123 2D Lung Models Market, by Region, 2022-2029 (USD Million)
Table 124 2D Lung Models Market, by Type, 2022-2029 (USD Million)
Table 125 Fresh Lung Cells Market, by Region, 2022-2029 (USD Million)
Table 126 Cryopreserved Lung Cells Market, by Region, 2022-2029 (USD Million)
Table 127 Other 2D Lung Models Market, by Region, 2022-2029 (USD Million)
Table 128 3D Lung Models Market, by Region, 2022-2029 (USD Million)
Table 129 3D Lung Models Market, by Type, 2022-2029 (USD Million)
Table 130 Lung Organoids Market, by Region, 2022-2029 (USD Million)
Table 131 3D Bioprinted Lung Models Market, by Region, 2022-2029 (USD Million)
Table 132 Lung Spheroids Market, by Region, 2022-2029 (USD Million)
Table 133 Other 3D Lung Models Market, by Region, 2022-2029 (USD Million)
Table 134 Other Products: Key Products Offered, by Company
Table 135 Brain, Central Nervous System, and Breast Cancer Incidence, 2022
Table 136 Other Human Organoid Products Market, by Region, 2022-2029 (USD Million)
Table 137 North America: Other Human Organoid Products Market, by Country, 2022-2029 (USD Million)
Table 138 Europe: Other Human Organoid Products Market, by Country, 2022-2029 (USD Million)
Table 139 Asia-Pacific: Other Human Organoid Products Market, by Country, 2022-2029 (USD Million)
Table 140 Latin America: Other Human Organoid Products Market, by Country, 2022-2029 (USD Million)
Table 141 Other Human Organoid Products Market, by Type, 2022-2029 (USD Million)
Table 142 2D Models (Other Products) Market, by Region, 2022-2029 (USD Million)
Table 143 2D Models (Other Products) Market, by Type, 2022-2029 (USD Million)
Table 144 Fresh Cells (Other Products) Market, by Region, 2022-2029 (USD Million)
Table 145 Cryopreserved Cells (Other Products) Market, by Region, 2022-2029 (USD Million)
Table 146 Other 2D Models (Other Products) Market, by Region, 2022-2029 (USD Million)
Table 147 3D Models (Other Products) Market, by Region, 2022-2029 (USD Million)
Table 148 3D Models (Other Products) Market, by Type, 2022-2029 (USD Million)
Table 149 Organoids (Other Products) Market, by Region, 2022-2029 (USD Million)
Table 150 3D Bioprinted Models (Other Products) Market, by Region, 2022-2029 (USD Million)
Table 151 Spheroids (Other Products) Market, by Region, 2022-2029 (USD Million)
Table 152 Other 3D Models (Other Products) Market, by Region, 2022-2029 (USD Million)
Table 153 Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 154 Adult Stem Cells Market, by Region, 2022-2029 (USD Million)
Table 155 North America: Adult Stem Cells Market, by Country, 2022-2029 (USD Million)
Table 156 Europe: Adult Stem Cells Market, by Country, 2022-2029 (USD Million)
Table 157 Asia-Pacific: Adult Stem Cells Market, by Country, 2022-2029 (USD Million)
Table 158 Latin America: Adult Stem Cells Market, by Country, 2022-2029 (USD Million)
Table 159 Induced Pluripotent Stem Cells: Key Products Offered, by Company
Table 160 Induced Pluripotent Stem Cells Market, by Region, 2022-2029 (USD Million)
Table 161 North America: Induced Pluripotent Stem Cells Market, by Country, 2022-2029 (USD Million)
Table 162 Europe: Induced Pluripotent Stem Cells Market, by Country, 2022-2029 (USD Million)
Table 163 Asia-Pacific: Induced Pluripotent Stem Cells Market, by Country, 2022-2029 (USD Million)
Table 164 Latin America: Induced Pluripotent Stem Cells Market, by Country, 2022-2029 (USD Million)
Table 165 Embryonic Stem Cells Market, by Region, 2022-2029 (USD Million)
Table 166 North America: Embryonic Stem Cells Market, by Country, 2022-2029 (USD Million)
Table 167 Europe: Embryonic Stem Cells Market, by Country, 2022-2029 (USD Million)
Table 168 Asia-Pacific: Embryonic Stem Cells Market, by Country, 2022-2029 (USD Million)
Table 169 Latin America: Embryonic Stem Cells Market, by Country, 2022-2029 (USD Million)
Table 170 Other Sources: Key Products Offered, by Company
Table 171 Other Human Organoid Sources Market, by Region, 2022-2029 (USD Million)
Table 172 North America: Other Human Organoid Sources Market, by Country, 2022-2029 (USD Million)
Table 173 Europe: Other Human Organoid Sources Market, by Country, 2022-2029 (USD Million)
Table 174 Asia-Pacific: Other Human Organoid Sources Market, by Country, 2022-2029 (USD Million)
Table 175 Latin America: Other Human Organoid Sources Market, by Country, 2022-2029 (USD Million)
Table 176 Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 177 Ready-To-Use Products Market: Key Products, by Company
Table 178 Ready-To-Use Human Organoid Products Market, by Region, 2022-2029 (USD Million)
Table 179 North America: Ready-To-Use Human Organoid Products Market, by Country, 2022-2029 (USD Million)
Table 180 Europe: Ready-To-Use Human Organoid Products Market, by Country, 2022-2029 (USD Million)
Table 181 Asia-Pacific: Ready-To-Use Human Organoid Products Market, by Country, 2022-2029 (USD Million)
Table 182 Latin America: Ready-To-Use Human Organoid Products Market, by Country, 2022-2029 (USD Million)
Table 183 Customizable Human Organoid Products Market, by Region, 2022-2029 (USD Million)
Table 184 North America: Customizable Human Organoid Products Market, by Country, 2022-2029 (USD Million)
Table 185 Europe: Customizable Human Organoid Products Market, by Country, 2022-2029 (USD Million)
Table 186 Asia-Pacific: Customizable Human Organoid Products Market, by Country, 2022-2029 (USD Million)
Table 187 Latin America: Customizable Human Organoid Products Market, by Country, 2022-2029 (USD Million)
Table 188 Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 189 Human Organoids Market for Matrigel Matrix Culture, by Region, 2022-2029 (USD Million)
Table 190 North America: Human Organoids Market for Matrigel Matrix Culture, by Country, 2022-2029 (USD Million)
Table 191 Europe: Human Organoids Market for Matrigel Matrix Culture, by Country, 2022-2029 (USD Million)
Table 192 Asia-Pacific: Human Organoids Market for Matrigel Matrix Culture, by Country, 2022-2029 (USD Million)
Table 193 Latin America: Human Organoids Market for Matrigel Matrix Culture, by Country, 2022-2029 (USD Million)
Table 194 Human Organoids Market for Air-Liquid Interface Culture, by Region, 2022-2029 (USD Million)
Table 195 North America: Human Organoids Market for Air-Liquid Interface Culture, by Country, 2022-2029 (USD Million)
Table 196 Europe: Human Organoids Market for Air-Liquid Interface Culture, by Country, 2022-2029 (USD Million)
Table 197 Asia-Pacific: Human Organoids Market for Air-Liquid Interface Culture, by Country, 2022-2029 (USD Million)
Table 198 Latin America: Human Organoids Market for Air-Liquid Interface Culture, by Country, 2022-2029 (USD Million)
Table 199 Human Organoids Market for Suspension Culture, by Region, 2022-2029 (USD Million)
Table 200 North America: Human Organoids Market for Suspension Culture, by Country, 2022-2029 (USD Million)
Table 201 Europe: Human Organoids Market for Suspension Culture, by Country, 2022-2029 (USD Million)
Table 202 Asia-Pacific: Human Organoids Market for Suspension Culture, by Country, 2022-2029 (USD Million)
Table 203 Latin America: Human Organoids Market for Suspension Culture, by Country, 2022-2029 (USD Million)
Table 204 Human Organoids Market for 3D Bioprinting Culture, by Region, 2022-2029 (USD Million)
Table 205 North America: Human Organoids Market for 3D Bioprinting Culture, by Country, 2022-2029 (USD Million)
Table 206 Europe: Human Organoids Market for 3D Bioprinting Culture, by Country, 2022-2029 (USD Million)
Table 207 Asia-Pacific: Human Organoids Market for 3D Bioprinting Culture, by Country, 2022-2029 (USD Million)
Table 208 Latin America: Human Organoids Market for 3D Bioprinting Culture, by Country, 2022-2029 (USD Million)
Table 209 Human Organoids Market for Other Culture Methods, by Region, 2022-2029 (USD Million)
Table 210 North America: Human Organoids Market for Other Culture Methods, by Country, 2022-2029 (USD Million)
Table 211 Europe: Human Organoids Market for Other Culture Methods, by Country, 2022-2029 (USD Million)
Table 212 Asia-Pacific: Human Organoids Market for Other Culture Methods, by Country, 2022-2029 (USD Million)
Table 213 Latin America: Human Organoids Market for Other Culture Methods, by Country, 2022-2029 (USD Million)
Table 214 Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 215 Incidence of Cancer Cases Worldwide, in 2022 vs 2045, by Cancer Type
Table 216 Human Organoids Market for Oncology, by Region, 2022-2029 (USD Million)
Table 217 North America: Human Organoids Market for Oncology, by Country, 2022-2029 (USD Million)
Table 218 Europe: Human Organoids Market for Oncology, by Country, 2022-2029 (USD Million)
Table 219 Asia-Pacific: Human Organoids Market for Oncology, by Country, 2022-2029 (USD Million)
Table 220 Latin America: Human Organoids Market for Oncology, by Country, 2022-2029 (USD Million)
Table 221 Human Organoids Market for Liver Diseases, by Region, 2022-2029 (USD Million)
Table 222 North America: Human Organoids Market for Liver Diseases, by Country, 2022-2029 (USD Million)
Table 223 Europe: Human Organoids Market for Liver Diseases, by Country, 2022-2029 (USD Million)
Table 224 Asia-Pacific: Human Organoids Market for Liver Diseases, by Country, 2022-2029 (USD Million)
Table 225 Latin America: Human Organoids Market for Liver Diseases, by Country, 2022-2029 (USD Million)
Table 226 Human Organoids Market for Gastrointestinal Diseases, by Region, 2022-2029 (USD Million)
Table 227 North America: Human Organoids Market for Gastrointestinal Diseases, by Country, 2022-2029 (USD Million)
Table 228 Europe: Human Organoids Market for Gastrointestinal Diseases, by Country, 2022-2029 (USD Million)
Table 229 Asia-Pacific: Human Organoids Market for Gastrointestinal Diseases, by Country, 2022-2029 (USD Million)
Table 230 Latin America: Human Organoids Market for Gastrointestinal Diseases, by Country, 2022-2029 (USD Million)
Table 231 Human Organoids Market for Cardiovascular Diseases, by Region, 2022-2029 (USD Million)
Table 232 North America: Human Organoids Market for Cardiovascular Diseases, by Country, 2022-2029 (USD Million)
Table 233 Europe: Human Organoids Market for Cardiovascular Diseases, by Country, 2022-2029 (USD Million)
Table 234 Asia-Pacific: Human Organoids Market for Cardiovascular Diseases, by Country, 2022-2029 (USD Million)
Table 235 Latin America: Human Organoids Market for Cardiovascular Diseases, by Country, 2022-2029 (USD Million)
Table 236 Human Organoids Market for Infectious Diseases by Region, 2022-2029 (USD Million)
Table 237 North America: Human Organoids Market for Infectious Diseases, by Country, 2022-2029 (USD Million)
Table 238 Europe: Human Organoids Market for Infectious Diseases, by Country, 2022-2029 (USD Million)
Table 239 Asia-Pacific: Human Organoids Market for Infectious Diseases, by Country, 2022-2029 (USD Million)
Table 240 Latin America: Human Organoids Market for Infectious Diseases, by Country, 2022-2029 (USD Million)
Table 241 Human Organoids Market for Neurological Disorders, by Region, 2022-2029 (USD Million)
Table 242 North America: Human Organoids Market for Neurological Disorders, by Country, 2022-2029 (USD Million)
Table 243 Europe: Human Organoids Market for Neurological Disorders, by Country, 2022-2029 (USD Million)
Table 244 Asia-Pacific: Human Organoids Market for Neurological Disorders, by Country, 2022-2029 (USD Million)
Table 245 Latin America: Human Organoids Market for Neurological Disorders, by Country, 2022-2029 (USD Million)
Table 246 Human Organoids Market for Other Disease Areas, by Region, 2022-2029 (USD Million)
Table 247 North America: Human Organoids Market for Other Disease Areas, by Country, 2022-2029 (USD Million)
Table 248 Europe: Human Organoids Market for Other Disease Areas, by Country, 2022-2029 (USD Million)
Table 249 Asia-Pacific: Human Organoids Market for Other Disease Areas, by Country, 2022-2029 (USD Million)
Table 250 Latin America: Human Organoids Market for Other Disease Areas, by Country, 2022-2029 (USD Million)
Table 251 Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 252 Human Organoids Market for Developmental Biology, by Region, 2022-2029 (USD Million)
Table 253 North America: Human Organoids Market for Developmental Biology, by Country, 2022-2029 (USD Million)
Table 254 Europe: Human Organoids Market for Developmental Biology, by Country, 2022-2029 (USD Million)
Table 255 Asia-Pacific: Human Organoids Market for Developmental Biology, by Country, 2022-2029 (USD Million)
Table 256 Latin America: Human Organoids Market for Developmental Biology, by Country, 2022-2029 (USD Million)
Table 257 Human Organoids Market for Drug Toxicity & Efficacy Testing, by Region, 2022-2029 (USD Million)
Table 258 North America: Human Organoids Market for Drug Toxicity & Efficacy Testing, by Country, 2022-2029 (USD Million)
Table 259 Europe: Human Organoids Market for Drug Toxicity & Efficacy Testing, by Country, 2022-2029 (USD Million)
Table 260 Asia-Pacific: Human Organoids Market for Drug Toxicity & Efficacy Testing, by Country, 2022-2029 (USD Million)
Table 261 Latin America: Human Organoids Market for Drug Toxicity & Efficacy Testing, by Country, 2022-2029 (USD Million)
Table 262 Human Organoids Market for Disease Pathology, by Region, 2022-2029 (USD Million)
Table 263 North America: Human Organoids Market for Disease Pathology, by Country, 2022-2029 (USD Million)
Table 264 Europe: Human Organoids Market for Disease Pathology, by Country, 2022-2029 (USD Million)
Table 265 Asia-Pacific: Human Organoids Market for Disease Pathology, by Country, 2022-2029 (USD Million)
Table 266 Latin America: Human Organoids Market for Disease Pathology, by Country, 2022-2029 (USD Million)
Table 267 Human Organoids Market for Personalized Medicine, by Region, 2022-2029 (USD Million)
Table 268 North America: Human Organoids Market for Personalized Medicine, by Country, 2022-2029 (USD Million)
Table 269 Europe: Human Organoids Market for Personalized Medicine, by Country, 2022-2029 (USD Million)
Table 270 Asia-Pacific: Human Organoids Market for Personalized Medicine, by Country, 2022-2029 (USD Million)
Table 271 Latin America: Human Organoids Market for Personalized Medicine, by Country, 2022-2029 (USD Million)
Table 272 Human Organoids Market for Regenerative Medicine, by Region, 2022-2029 (USD Million)
Table 273 North America: Human Organoids Market for Regenerative Medicine, by Country, 2022-2029 (USD Million)
Table 274 Europe: Human Organoids Market for Regenerative Medicine, by Country, 2022-2029 (USD Million)
Table 275 Asia-Pacific: Human Organoids Market for Regenerative Medicine, by Country, 2022-2029 (USD Million)
Table 276 Latin America: Human Organoids Market for Regenerative Medicine, by Country, 2022-2029 (USD Million)
Table 277 Human Organoids Market for Other Applications, by Region, 2022-2029 (USD Million)
Table 278 North America: Human Organoids Market for Other Applications, by Country, 2022-2029 (USD Million)
Table 279 Europe: Human Organoids Market for Other Applications, by Country, 2022-2029 (USD Million)
Table 280 Asia-Pacific: Human Organoids Market for Other Applications, by Country, 2022-2029 (USD Million)
Table 281 Latin America: Human Organoids Market for Other Applications, by Country, 2022-2029 (USD Million)
Table 282 Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 283 Human Organoids Market for Pharmaceutical & Biotechnology Companies, by Region, 2022-2029 (USD Million)
Table 284 North America: Human Organoids Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 285 Europe: Human Organoids Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 286 Asia-Pacific: Human Organoids Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 287 Latin America: Human Organoids Market for Pharmaceutical & Biotechnology Companies, by Country, 2022-2029 (USD Million)
Table 288 Human Organoids Market for Contract Research Organizations, by Region, 2022-2029 (USD Million)
Table 289 North America: Human Organoids Market for Contract Research Organizations, by Country, 2022-2029 (USD Million)
Table 290 Europe: Human Organoids Market for Contract Research Organizations, by Country, 2022-2029 (USD Million)
Table 291 Asia-Pacific: Human Organoids Market for Contract Research Organizations, by Country, 2022-2029 (USD Million)
Table 292 Latin America: Human Organoids Market for Contract Research Organizations, by Country, 2022-2029 (USD Million)
Table 293 Human Organoids Market for Academic & Research Institutes, by Region, 2022-2029 (USD Million)
Table 294 North America: Human Organoids Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 295 Europe: Human Organoids Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 296 Asia-Pacific: Human Organoids Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 297 Latin America: Human Organoids Market for Academic & Research Institutes, by Country, 2022-2029 (USD Million)
Table 298 Human Organoids Market for Other End-users, by Region, 2022-2029 (USD Million)
Table 299 North America: Human Organoids Market for Other End-users, by Country, 2022-2029 (USD Million)
Table 300 Europe: Human Organoids Market for Other End-users, by Country, 2022-2029 (USD Million)
Table 301 Asia-Pacific: Human Organoids Market for Other End-users, by Country, 2022-2029 (USD Million)
Table 302 Latin America: Human Organoids Market for Other End-users, by Country, 2022-2029 (USD Million)
Table 303 Human Organoids Market, by Region, 2022-2029 (USD Million)
Table 304 North America: Estimated Number of New Cancer Cases from 0 to 85+ Years of Age, 2022-2045
Table 305 North America: Human Organoids Market, by Country, 2022-2029 (USD Million)
Table 306 North America: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 307 North America: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 308 North America: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 309 North America: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 310 North America: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 311 North America: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 312 North America: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 313 US: Cancer Incidence, Mortality, and Prevalence, by Type, 2022
Table 314 US: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 315 US: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 316 US: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 317 US: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 318 US: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 319 US: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 320 US: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 321 Estimated Prevalence of Diabetes in Canada, 2022 vs. 2023
Table 322 Canada: Five Most-Reported Causes of Cancer-Related Mortality, 2024
Table 323 Canada: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 324 Canada: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 325 Canada: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 326 Canada: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 327 Canada: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 328 Canada: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 329 Canada: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 330 Europe: Estimated Number of New Cancer Cases from 2022 to 2045, Both Sexes, Age [0-85+]
Table 331 Europe: Human Organoids Market, by Country, 2022-2029 (USD Million)
Table 332 Europe: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 333 Europe: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 334 Europe: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 335 Europe: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 336 Europe: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 337 Europe: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 338 Europe: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 339 Germany: Cancer Incidence, Mortality, and Prevalence, by Type, 2022
Table 340 Germany: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 341 Germany: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 342 Germany: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 343 Germany: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 344 Germany: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 345 Germany: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 346 Germany: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 347 UK: Incidence and Mortality Rate of Heart and Circulatory Diseases (Cvd), 2024
Table 348 UK: Cancer Incidence, Mortality, and Prevalence, by Type, 2022
Table 349 UK: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 350 UK: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 351 UK: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 352 UK: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 353 UK: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 354 UK: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 355 UK: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 356 France: Cancer Incidence, Mortality, and Prevalence, by Type, 2022
Table 357 France: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 358 France: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 359 France: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 360 France: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 361 France: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 362 France: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 363 France: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 364 Italy: Cancer Incidence, Mortality, and Prevalence, by Type, 2022
Table 365 Italy: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 366 Italy: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 367 Italy: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 368 Italy: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 369 Italy: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 370 Italy: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 371 Italy: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 372 Spain: Cancer Incidence, 2022 vs 2023
Table 373 Spain: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 374 Spain: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 375 Spain: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 376 Spain: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 377 Spain: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 378 Spain: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 379 Spain: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 380 Rest of Europe: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 381 Rest of Europe: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 382 Rest of Europe: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 383 Rest of Europe: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 384 Rest of Europe: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 385 Rest of Europe: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 386 Rest of Europe: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 387 Asia-Pacific: Estimated Number of New Cancer Cases from 2022 to 2045, Both Sexes, Age [0-85+]
Table 388 Asia-Pacific: Human Organoids Market, by Country, 2022-2029 (USD Million)
Table 389 Asia-Pacific: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 390 Asia-Pacific: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 391 Asia-Pacific: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 392 Asia-Pacific: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 393 Asia-Pacific: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 394 Asia-Pacific: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 395 Asia-Pacific: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 396 China: Cancer Incidence, Mortality, and Prevalence, by Type, 2022
Table 397 China: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 398 China: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 399 China: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 400 China: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 401 China: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 402 China: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 403 China: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 404 Japan: Cancer Incidence, Mortality, and Prevalence, by Type, 2022
Table 405 Japan: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 406 Japan: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 407 Japan: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 408 Japan: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 409 Japan: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 410 Japan: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 411 Japan: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 412 India: Cancer Incidence, Mortality, and Prevalence, by Type, 2022
Table 413 India: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 414 India: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 415 India: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 416 India: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 417 India: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 418 India: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 419 India: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 420 Australia: Cancer Incidence, Mortality, and Prevalence, by Type, 2022
Table 421 Australia: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 422 Australia: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 423 Australia: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 424 Australia: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 425 Australia: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 426 Australia: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 427 Australia: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 428 South Korea: Cancer Incidence, Mortality and Prevalence, by Type, 2022
Table 429 South Korea: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 430 South Korea: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 431 South Korea: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 432 South Korea: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 433 South Korea: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 434 South Korea: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 435 South Korea: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 436 Rest of Asia-Pacific: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 437 Rest of Asia-Pacific: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 438 Rest of Asia-Pacific: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 439 Rest of Asia-Pacific: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 440 Rest of Asia-Pacific: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 441 Rest of Asia-Pacific: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 442 Rest of Asia-Pacific: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 443 Latin America: Estimated Number of Cancer New Cases from 2022 to 2045, Both Sexes, Age [0-85+]
Table 444 Latin America: Human Organoids Market, by Country, 2022-2029 (USD Million)
Table 445 Latin America: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 446 Latin America: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 447 Latin America: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 448 Latin America: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 449 Latin America: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 450 Latin America: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 451 Latin America: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 452 Brazil: Cancer Incidence, Mortality, and Prevalence, by Type, 2022
Table 453 Brazil: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 454 Brazil: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 455 Brazil: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 456 Brazil: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 457 Brazil: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 458 Brazil: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 459 Brazil: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 460 Mexico: Cancer Incidence, Mortality, and Prevalence, by Type, 2022
Table 461 Mexico: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 462 Mexico: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 463 Mexico: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 464 Mexico: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 465 Mexico: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 466 Mexico: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 467 Mexico: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 468 Rest of Latin America: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 469 Rest of Latin America: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 470 Rest of Latin America: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 471 Rest of Latin America: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 472 Rest of Latin America: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 473 Rest of Latin America: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 474 Rest of Latin America: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 475 Africa: Estimated Number of New Cancer Cases Between 0 to 85+ of Age, 2022-2045
Table 476 Middle East & Africa: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 477 Middle East & Africa: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 478 Middle East & Africa: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 479 Middle East & Africa: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 480 Middle East & Africa: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 481 Middle East & Africa: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 482 Middle East & Africa: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 483 GCC Countries: Human Organoids Market, by Product, 2022-2029 (USD Million)
Table 484 GCC Countries: Human Organoids Market, by Source, 2022-2029 (USD Million)
Table 485 GCC Countries: Human Organoids Market, by Type, 2022-2029 (USD Million)
Table 486 GCC Countries: Human Organoids Market, by Culture Method, 2022-2029 (USD Million)
Table 487 GCC Countries: Human Organoids Market, by Disease Area, 2022-2029 (USD Million)
Table 488 GCC Countries: Human Organoids Market, by Application, 2022-2029 (USD Million)
Table 489 GCC Countries: Human Organoids Market, by End-user, 2022-2029 (USD Million)
Table 490 Overview of Strategies Deployed by Key Players in Human Organoids Market
Table 491 Human Organoids Market: Degree of Competition
Table 492 Human Organoids Market: Region Footprint
Table 493 Human Organoids Market: Product Footprint
Table 494 Human Organoids Market: Source Footprint
Table 495 Human Organoids Market: Application Footprint
Table 496 Human Organoids Market: Detailed List of Key Startup/SME Players
Table 497 Human Organoids Market: Competitive Benchmarking of Startup/SME Players
Table 498 Human Organoids Market: Product Launches, January 2021- August 2024
Table 499 Human Organoids Market: Deals, January 2021-August 2024
Table 500 Thermo Fisher Scientific: Company Overview
Table 501 Thermo Fisher Scientific: Products Offered
Table 502 Thermo Fisher Scientific: Product Launches, January 2021-August 2024
Table 503 Thermo Fisher Scientific: Deals, January 2021-August 2024
Table 504 Corning Incorporated: Company Overview
Table 505 Corning Incorporated: Products Offered
Table 506 Corning Incorporated: Deals, January 2021-August 2024
Table 507 Merck: Company Overview
Table 508 Merck: Products Offered
Table 509 Merck: Deals, January 2021-August 2024
Table 510 Merck: Expansions, January 2021-August 2024
Table 511 Bioivt: Company Overview
Table 512 Bioivt: Products Offered
Table 513 Bioivt: Deals, January 2021-August 2024
Table 514 Hub Organoids: Company Overview
Table 515 Hub Organoids: Products Offered
Table 516 Hub Organoids: Deals, January 2021-August 2024
Table 517 Bico: Company Overview
Table 518 Bico: Products Offered
Table 519 Bico: Product Launches, January 2021-August 2024
Table 520 Bico: Deals, January 2021-June 2024
Table 521 Bico: Other Developments, January 2021-August 2024
Table 522 Becytes Biotechnologies: Company Overview
Table 523 Becytes Biotechnologies: Products Offered
Table 524 Insphero: Company Overview
Table 525 Insphero: Products Offered
Table 526 Insphero: Deals, January 2021-August 2024
Table 527 Gba Group: Company Overview
Table 528 Gba Group: Products Offered
Table 529 Gba Group: Deals, January 2021-August 2024
Table 530 Kirkstall: Company Overview
Table 531 Kirkstall: Products Offered
Table 532 Mimetas: Company Overview
Table 533 Mimetas: Products Offered
Table 534 Mimetas: Product Launches, January 2021-August 2024
Table 535 Mimetas: Deals, January 2021-August 2024
Table 536 Neuromics: Company Overview
Table 537 Neuromics: Products Offered
Table 538 Primacyt Cell Culture Technology GmbH: Company Overview
Table 539 Primacyt Cell Culture Technology GmbH: Products Offered
Table 540 Stemcell Technologies: Company Overview
Table 541 Stemcell Technologies: Products Offered
Table 542 Stemcell Technologies: Deals, January 2021-August 2024
Table 543 Stemcell Technologies: Expansions, January 2021-August 2024

Figure 1 Human Organoids Market: Research Design Methodology
Figure 2 Breakdown of Primary Interviews: Supply Side and Demand Side Participants
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 4 Bottom-Up Approach: Company Revenue Estimation Approach
Figure 5 CAGR Projections: Supply Side Analysis
Figure 6 Human Organoids Market: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Human Organoids Market, by Product, 2024 vs. 2029 (USD Million)
Figure 9 Human Organoids Market, by Source, 2024 vs. 2029 (USD Million)
Figure 10 Human Organoids Market, by Type, 2024 vs. 2029 (USD Million)
Figure 11 Human Organoids Market, by Culture Method, 2024 vs. 2029 (USD Million)
Figure 12 Human Organoids Market, by Disease Area, 2024 vs. 2029 (USD Million)
Figure 13 Human Organoids Market, by Application, 2024 vs. 2029 (USD Million)
Figure 14 Human Organoids Market, by End-user, 2024 vs. 2029 (USD Million)
Figure 15 Human Organoids Market, by Region, 2024 vs. 2029 (USD Million)
Figure 16 Growing Focus on Developing Alternatives for Animal Testing Models to Drive Market Growth
Figure 17 Liver Models to Dominate Market Till 2029
Figure 18 Adult Stem Cells Segment to Hold Largest Share Till 2029
Figure 19 Ready-To-Use Products Segment to Retain Market Leadership
Figure 20 Developmental Biology and Drug Toxicity & Efficacy Testing to Command Largest Shares
Figure 21 Pharmaceutical & Biotechnology Companies Segment to Dominate Market in 2029
Figure 22 Asia-Pacific to Register Highest Growth Rate During Forecast Period
Figure 23 Human Organoids Market: Drivers, Restraints, Opportunities, and Challenges
Figure 24 Number of Clinical Trials, by Country, 2022
Figure 25 Number of Articles Related to Human Organoids, 2018-2023
Figure 26 US: Number of Organ Transplants (2024)
Figure 27 Average Selling Price of Fresh Cells (2024)
Figure 28 Patent Analysis for Human Organoids (January 2014-December 2023)
Figure 29 Value Chain Analysis: Major Value Added During Manufacturing and Assembly Phases
Figure 30 Human Organoids Market: Supply Chain Analysis
Figure 31 Human Organoids Market: Ecosystem Analysis
Figure 32 Human Organoids Market: Porter's Five Forces Analysis
Figure 33 Influence of Stakeholders on Buying Process of Human Organoids
Figure 34 Key Buying Criteria for Human Organoids
Figure 35 Human Organoids Market: Trends and Disruptions Impacting Customer's Business
Figure 36 Human Organoids Market: Deals and Funding
Figure 37 Market Potential of AI to Enhance Research and Development in Human Organoids Market
Figure 38 North America: Human Organoids Market Snapshot
Figure 39 Asia-Pacific: Human Organoids Market Snapshot
Figure 40 Revenue Analysis of Key Players in Human Organoids Market (2021-2023)
Figure 41 Market Share Analysis of Key Players in Human Organoids Market (2023)
Figure 42 Human Organoids Market: Company Evaluation Matrix (Key Players), 2023
Figure 43 Human Organoids Market: Company Footprint
Figure 44 Human Organoids Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 45 EV/EBITDA of Key Vendors
Figure 46 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 47 Human Organoids Market: Brand Comparison for Hepatocytes
Figure 48 Thermo Fisher Scientific: Company Snapshot
Figure 49 Corning Incorporated: Company Snapshot
Figure 50 Merck: Company Snapshot
Figure 51 Bico: Company Snapshot